Ajanta Pharma Q3 Net Profit Rises 38% to Rs 85 Crore

Published: 28th January 2015 04:03 PM  |   Last Updated: 28th January 2015 04:03 PM   |  A+A-


NEW DELHI: Ajanta Pharma today reported 35.7 per cent increase in its net profit at Rs 84.71 crore for the quarter ended December on account of robust sales in domestic market.

The company had posted a net profit of Rs 62.42 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 356.28 crore for the third quarter as compared to Rs 292.59 crore for the same period of corresponding financial year, Ajanta Pharma Ltd said in a filing to the BSE.

"All our growth drivers are performing as per our plans and expectations. We continue to post above industry growth in India and emerging markets in our branded generic business segment," Ajanta Pharma Joint Managing Director Rajesh Agrawal


The company's Dahej (Gujarat) formulation facility implementation has been completed and is undergoing qualification, he added.

"We expect to take regulatory filing batches from Q1 FY16 onwards. Addition of this facility will ensure that we have adequate capacities to cater to our growths in coming years," Agrawal said.

Ajanta Pharma shares were trading 11.25 per cent up at Rs 2,665.15 apiece during afternoon session on the BSE.

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp